Sectors

NXTS
Nexentis Technologies Inc.
0.86
2 x 1.01
2 x 1.83
bid
ask
-
0.03
2.98%
2 @ 07:26 PM
0.84 -0.02 (2.45%)
Ytd-92.71%
1y-97.14%
0.83
day range
0.96
0.86
52 week range
31.36
Open0.87Prev Close0.88Low0.83High0.96Mkt Cap1.25M
Vol178.84KAvg Vol347.07KEPS-21.55P/EN/AForward P/EN/A
Beta1.84Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg1.65200-d Avg5.081yr Est0.00

NXTS News

benzinga.com
Nexentis Technologies Unit MitoCareX Bio Launches Its Computational Drug Discovery Infrastructure On

The transition is designed to provide MitoCareX with a secure and flexible computing environment for

Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
globenewswire.com
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud

Deployment on Google Cloud Platform is designed to enhance computational capacity, data governance a

Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
globenewswire.com
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Pr

Leading computational chemistry expert to advise MitoCareX as it expands its in silico drug-discover

Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
globenewswire.com
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Futur

Evaluation of additional commercially available approaches for obtaining proteins is intended to enh

benzinga.com
Nexentis Technologies Subsidiary MitoCareX Bio Narrows Its SLC Transport Protein Candidates To Selec

As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign
globenewswire.com
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discover

Following its broad structural analysis of the human SLC transport protein family, MitoCareX advance

Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative
globenewswire.com
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and In

MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small m

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment
globenewswire.com
Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuat

Neve Yarak, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Ne

Crude Oil Down Over 1%; US Manufacturing PMI Surges In June
benzinga.com
Crude Oil Down Over 1%; US Manufacturing PMI Surges In June

US stocks lower, Nasdaq falls 500 points. Dow down 0.04%, Nasdaq 1.91%, S&P 500 1.27%. Consumer

Dow Falls Over 300 Points; Korn Ferry Earnings Top Views
benzinga.com
Dow Falls Over 300 Points; Korn Ferry Earnings Top Views

US stocks down as Dow falls 300 points, while S&P 500 and NASDAQ also decrease. Consumer staples

Crude Oil Falls Over 2%; Getty Images Shares Spike Higher
benzinga.com
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 poi

Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results
benzinga.com
Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results

US stocks rise, Dow up over 200 points. Financial shares jump 0.9% while communication services stoc

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
globenewswire.com
Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and

MITOLINE ® -Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in

Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
globenewswire.com
Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins t

Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Ne

Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe

Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
globenewswire.com
Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit

Ness Ziona, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nex

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone
globenewswire.com
Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug

MITOLINE-Powered Platform Delivers Optimized Hit Molecule, Strengthening the Foundation for Future P

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™
globenewswire.com
Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platf

Neve Yarak, Israel, May 05, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS), ("Ne

Contrasting Nexentis Technologies (NASDAQ:NXTS) & Scheid Vineyards (OTCMKTS:SVIN)
defenseworld.net
Contrasting Nexentis Technologies (NASDAQ:NXTS) & Scheid Vineyards (OTCMKTS:SVIN)

Nexentis Technologies (NASDAQ: NXTS - Get Free Report) and Scheid Vineyards (OTCMKTS:SVIN - Get Free

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform
globenewswire.com
Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech P

Visit Nexentis at: www. nexentistech. com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Nex